Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma

Thyroid

Volumn 7, Issue 5, 1997, Pages 705-712

  Alam, Md Sayeedul ^a,b   Takeuchi, Ryo ^a   Kasagi, Kanji ^a   Misaki, Takashi ^a   Miyamoto, Shinichi ^a   Iida, Yasuhiro ^a   Hidaka, Akinari ^a   Konishi, Junji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; MEDRONATE TECHNETIUM TC 99M; THALLIUM 201; THYROGLOBULIN;

ADULT; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER SCINTISCANNING; CLINICAL ARTICLE; COLLIMATOR; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCINTILLATION CAMERA; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA;

EID: 0031424585     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1997.7.705     Document Type: Article

References (31)

1. Van Herle AJ, Uller RP 1975 Elevated serum thyroglobulin: a marker of metastases in differentiated thyroid carcinomas. J Clin Invest 56:272-275.
2. Black EG, Sheppard MC, Hoffenberg R 1987 Serial serum thyroglobulin measurement in management of differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 27:115-120.
3. Pacini F, Pinchera A, Giani C, Grosso L, Baschieri L 1980 Serum thyroglobulin concentrations and I-131 whole body scans in the diagnosis of metastases from differentiated thyroid carcinoma (after thyroidectomy). Clin Endocrinol (Oxf) 13:107-110.
4. Sheppard MC 1986 Serum thyroglobulin and thyroid cancer. Q J Med 59:429-433.
5. Barsano CP, Skosey C, DeGroot LJ, Refetoff S 1982 Serum thyroglobulin in the management of patients with thyroid cancer. Arch Intern Med 142:763-767.
6. Tang Fui SC, Hoffenberg R, Maisey MN, Black EG 1979 Serum thyroglobulin concentrations and whole-body radioiodine scan in follow-up of differentiated thyroid carcinoma after thyroid ablation. Br Med J 2:298-300.
7. Ramanna L, Waxman AD, Brachman MB, Sensel E, Tanasescu DE, Berman DS, Catz B, Braunstein GD 1985 Correlation of thyroglobulin measurements and radioiodine scans in follow-up of patients with thyroid cancer. Cancer 55:1525-1529.
8. Aschraft MV, Van Herle ÀJ 1981 The comparative value of serum thyroglobulin measurements and iodine-131 total body scans in the follow up study of patients with treated differentiated thyroid cancer. Am J Med 71:806-814.
9. Clacchio TA, LoGerfo P, Colacchio DA, Feind C 1982 Radioiodine total body scan verses serum thyroglobulin levels in follow-up of patients with thyroid cancer. Surgery 91:42-45.
10. Iida Y, Hidaka A, Hatabu H, Kasagi K, Konishi J 1990 Follow-up study of post-operative patients with thyroid cancer by thallium-201 scintigraphy and serum thyroglobulin measurement. J Nucl Med 32:2098-2100.
11. 131I therapy on the survival of patients with metastatic papillary or follicular thyroid carcinoma. J Clin Endocrinol Metab 36:1143-1146.
12. Sherman Jr CD 1990 Thyroid cancer. Manual of Clinical Oncology, 5th edition, UICC, Geneva, pp. 204-210.
13. Hudson TM 1987 Introduction: Radio-pathologic correlation of musculo-skeletal lesions. Williams & Wilkins, Baltimore,
14. Castilo LA, Yeh SD J, Leeper RD, Benua RS 1980 Bone scans in bone metastases from functioning thyroid carcinoma. Clin Nucl Med 5:200-209.
15. Heagy F. Radionuclides in the diagnosis of primary and metastatic thyroid carcinoma. Proceedings of 18th Clinical Conference; Ontario cancer treatment and research foundation, 1974.
16. Dibos PE, Wagner HN Jr 1986 Bone: Atlas of Nuclear Medicine, WB Saunders, Philadelphia.
17. Corcoran RJ, Thrall JH, Kyle RW, Kaminski RJ, Johnson MC 1976 Solitary abnormalities in bone scans of patients with extraosseous malignancies. Radiology 121:663-667.
18. Rappaport AH, Hoffer PB, Genant HK 1978 Unifocal bone findings by scintigraphy: Clinical significance in patients with known primary cancer. West J Med 129:188-192.
19. Tumeh SS, Beadle G, Kaplan WD 1985 Clinical significance of solitary rib lesions in patients with extra skeletal malignancy. J Nucl Med 26:1140-1143.
20. Maurea S, Lastoria S, Klain M, et al. Technetium-99m MIBI scan in the initial evaluation and post-surgical follow-up of thyroid cancer (Abstract). J Nucl Med 35:166.
21. Miyamoto S, Kasagi K, Alam MS, Misaki T, Konishi J 1997 Evaluation of technetium-99m MIBI scintigraphy in metastatic differentiated thyroid carcinoma. J Nucl Med 38:352-356.
22. Klain M, Maurea S, Lastoria S, Cuocolo A, Colao A, Salvatore M 1995 Technetium-99m Tetrofosmin imaging of differentiated mixed thyroid cancer. J Nucl Med 36:2248-2251.
23. Feine U, Lietzenmayer R, Hanke JP, Held J, Wohrle H, Muller SW 1996 Fluorine-18 FDG and Iodine-131 uptake in thyroid cancer. J Nucl Med 37:1468-1472.
24. Grunwald F, Schomburg A, Bender H, et al 1996 Fluorine-18 Fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 23:312-319.
25. Sisson JC, Ackermann RJ, Mayer MA, Wahl RL 1993 Up-take of 18-Fluoro-2 Deoxy-D-Glucose by thyroid cancer. Implications for diagnosis and therapy. J Clin Endocrinol Metab 77:1090-1094.
26. Tonami N, Hisada K 1980 T1-201 scintigraphy in post-operative detection of thyroid cancer: A comparative study with I-131. Radiology 136:461-164.
27. Ramanna L, Waxman A, Braunstein G 1991 Thallium-201 in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations. J Nucl Med 32:441-446.
28. Brown ML, Collier Jr. BD, Fogelman I 1993 Continuing Education: Bone Scintigraphy, Part 1: Oncology and infection. J Nucl Med 34:2236-2240.
29. Hirayu H, Izumi M, Morita S, Nagataki S, Sato K, Yamashita S, Koji T, Nagataki S 1983 Accumulation of radioactively labeled anti-thyroglobulin antibody by thyroid carcinoma. Onco Dev Biol Med 4:63-70.
30. Fairweather DS, Bradwell AR, Watson-James SF, Dykes PW, Chandler S, Hoffenberg R 1983 Detection of thyroid tumour using radiolabeled anti-thyroglobulin. Clin Endocrinol 18:563-570.
31. Shepherd PS, Lazarus CR, Mistry RD, Maisey MN 1985 Detection of thyroid tumour using a monoclonal 1-123 anti-human thyroglobulin antibody. Eur J Nucl Med 10:291-295.